Presented by

OVERVIEW
Stocktwits Top 25 Week 11

Welcome to the Stocktwits Top 25 Newsletter for Week 11 of 2025!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time. 

Here are the Stocktwits Top 25 Lists for Week 11:

P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

S&P 500
ST Top 25 S&P 500 💪

The S&P 500 Top 25 list (-2.09%) outperformed the S&P 500 index (-2.27%).

There were 7 major changes to the list this week.

SPONSORED
Last Day to Invest: CEO’s Self-Cure Turned $100M+ Dermatology Disrupter

👉 Survivor to founder… A deadly infection with a 70% fatality rate and no available cure couldn’t stop CEO Bradley Burnam. Instead, he invented his own cure and turned it into a $100M+ company with a mission to heal.

Now, Turn Therapeutics is aiming to develop life-changing therapies for advanced wound care, eczema, and onychomycosis– a combined $25B+ market.

🤝 Backed and funded… With $15M+ in total funding across all offerings, Turn Therapeutics also received a commitment from PE group, GEM, to purchase up to $75 million of stock upon a public listing. With its Nasdaq ticker secured (TTRX), the company is inviting all to be an early investor and join the momentum of a biotech company that has the potential to revolutionize healing.

⏰ Final chance… Campaign ends today, March 15— get your investment in by 11:59pm PST!

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.